Cargando…

Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force

Disseminating disease is a predictive and prognostic indicator of poor outcome in children with neuroblastoma. Its accurate and sensitive assessment can facilitate optimal treatment decisions. The International Neuroblastoma Risk Group (INRG) Task Force has defined standardised methods for the deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beiske, K, Burchill, S A, Cheung, I Y, Hiyama, E, Seeger, R C, Cohn, S L, Pearson, A D J, Matthay, K K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696761/ https://www.ncbi.nlm.nih.gov/pubmed/19401690 http://dx.doi.org/10.1038/sj.bjc.6605029

Ejemplares similares

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
por: Ambros, P F, et al.
Publicado: (2009)

Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
por: Matthay, K K, et al.
Publicado: (2010)

MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening
por: Iehara, T, et al.
Publicado: (2006)

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study
por: Wang, L L, et al.
Publicado: (2015)

Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells
por: Stockhausen, M-T, et al.
Publicado: (2005)

IMMUNOCYTOLOGICAL EFFECTS OF VARIED INOCULA OF INFLUENZA VIRUS
por: Watson, Barbara K.
Publicado: (1961)

Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase
por: Hiyoshi, H, et al.
Publicado: (2012)

Flow cytometry of bone marrow aspirates from neuroblastoma patients is a highly sensitive technique for quantification of low-level neuroblastoma
por: Jain, Neha, et al.
Publicado: (2021)

Neuroblastoma
por: Pearson, D.
Publicado: (1977)

Inhibition of Akt sensitises neuroblastoma cells to gold(III) porphyrin 1a, a novel antitumour drug induced apoptosis and growth inhibition
por: Li, W, et al.
Publicado: (2009)

Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
por: Matthay, K K, et al.
Publicado: (2000)

Bone Marrow Environment in Metastatic Neuroblastoma
por: Brignole, Chiara, et al.
Publicado: (2021)

Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort
por: Tadeo, Irene, et al.
Publicado: (2016)

Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study
por: Berbegall, Ana P., et al.
Publicado: (2018)

In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell Lines
por: Hiyama, Yoko, et al.
Publicado: (2022)

PCR-based amplification of circulating RNAs as prognostic and predictive biomarkers – Focus on neuroblastoma()
por: Brownhill, Sam C., et al.
Publicado: (2016)

Immunological detection of neuroblastoma cells in bone marrow harvested for autologous transplantation.
por: Combaret, V., et al.
Publicado: (1989)

Length of Telomeric Repeats in Neuroblastoma: Correlation with Prognosis and Other Biological Characteristics
por: Hiyama, Eiso, et al.
Publicado: (1992)

Enteric peripheral neuroblastoma in a calf
por: SAKAI, Yusuke, et al.
Publicado: (2019)

Single‐cell next‐generation sequencing of circulating tumor cells in patients with neuroblastoma
por: Kojima, Masato, et al.
Publicado: (2023)

Cell Proliferation in Neuroblastoma
por: Stafman, Laura L., et al.
Publicado: (2016)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

Genetic heterogeneity and clonal evolution in neuroblastoma
por: Mora, J, et al.
Publicado: (2001)

The Significance of Histopathologic Assessment in Bone Marrow Disease in Neuroblastoma
por: Ekmekci, Sumeyye, et al.
Publicado: (2022)

Study of Hemato-morphological Features in Neuroblastoma Infiltrating Marrow
por: Singh, Anurag, et al.
Publicado: (2022)

Bone marrow non-mesenchymal mononuclear cells induce functional differentiation of neuroblastoma cells
por: Phruksaniyom, Chareerut, et al.
Publicado: (2013)

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.
por: Favrot, M. C., et al.
Publicado: (1986)

Bone marrow-derived stromal cells are associated with gastric cancer progression
por: Kasashima, H, et al.
Publicado: (2015)

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
por: Schleiermacher, G, et al.
Publicado: (2012)

Genetic Predisposition to Neuroblastoma
por: Barr, Erin K., et al.
Publicado: (2018)

Immunocytological analysis of meiotic recombination in two anole lizards (Squamata, Dactyloidae)
por: Lisachov, Artem P., et al.
Publicado: (2017)

High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT–PCR mRNA expression profile
por: Baldewijns, M M, et al.
Publicado: (2007)

P01.16. A root extract of Helleborus niger possess cytotoxic properties in neuroblastoma cells
por: Delebinski, C, et al.
Publicado: (2012)

Apoptotic Cell Death in Neuroblastoma
por: Li, Yuanyuan, et al.
Publicado: (2013)

Circulating Tumor Cells in Neuroblastoma
por: Jain, Mili, et al.
Publicado: (2017)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

N-Cadherin in Neuroblastoma Disease: Expression and Clinical Significance
por: Lammens, Tim, et al.
Publicado: (2012)

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma.
por: Pritchard, J., et al.
Publicado: (1982)

Bone and bone marrow involvement in neuroblastoma: A case report
por: Huang, Can, et al.
Publicado: (2020)

In-vitro effects of hyperglycemia on survival of neuroblastoma (SHSY) cells
por: Cochet, K, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_esjiv57s7rmbtu16ngkjkdu677